Organon & Co. (OGN)

13.40 0.00 (0.00%) USD  |  NYSE  |  Jun 09, 16:00
13.40 0.00 (0.00%) After-Hours: 18:43
More

Organon SG&A Expense (Quarterly) : 424.00M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for OGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. 2.70B
Eli Lilly & Co. 2.934B
Ligand Pharmaceuticals, Inc. 20.84M
Veradermics, Inc. 8.937M
Johnson & Johnson 6.034B